Total Funding
30
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
115597
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Acquired by 
Roivant Sciences
Woody Sherman: CSOPast Role: Schrödinger, VP & Global Head of Applications Science
Scott Duncan: Director of CMCPast Role: Stealth BioTherapeutics, Director of Chemistry, Technical Operations
About the Company
Silicon Therapeutics is a fully integrated drug design, research, and development company. Their multi-disciplinary team is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology R&D. Their unique platform is purpose-built to develop novel small
molecule therapeutics to address biologically and genetically validated, but previously intractable, protein targets.
